cAMPfield Therapeutics
PrivateLast Round
Series A
Jun 18, 2026
Total Funding Raised
$360M
Company Overview
cAMPfield Therapeutics is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor for the treatment of inflammatory bowel disease (IBD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
cAMPfield Therapeutics Comps
Public and private peers based on sector, stage, and business model.
cAMPfield Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 18, 2026 | ||||
| Series A | May 20, 2026 |
cAMPfield Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A |
| RA Capital Management | Series A |
| Mountainfield Venture Partners | Series A |
| Forbion | Series A |
| Deep Track Capital | Series A |
| Frazier Life Sciences | Series A |
| Abingworth | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
$180M round with participation from RA Capital Management.
- May 20, 2026
$180M round led by Mountainfield Venture Partners.
cAMPfield Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about cAMPfield Therapeutics's valuation, stock price, and market status.
